Clinical Trial

Feasibility of the Glenrose Grocery Game for Cognitive and Functional Outcomes in Older Inpatients

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
Recruitment was impacted by the COVID-19 pandemic and had to be paused for several months due to restrictions on hospital access.
Summary
Older adults could benefit from computer serious games as a strategy for improving not only their cognitive functions but also their functioning and performance in daily activities, which are often compromised with age. A computer serious game is one designed for a primary purpose other than pure entertainment. Few computer games had been developed to emulate instrumental activities of daily living (IADLs), such as money management (e.g., shopping or paying bills). To fill this gap, occupational therapists at the Glenrose Rehabilitation Hospital (GRH) developed the Glenrose Grocery Game (GGG). At the time, the game had not yet been tested. Thus, the purpose of this feasibility study was to explore whether playing the GGG as part of the rehabilitation program at the GRH had an effect on specific mental functions (memory and attention), occupational performance in money management tasks, and satisfaction with occupational performance in older adults. In this study, we compared the outcomes of 7 participants who played the GGG (intervention group) with those of 8 different participants who received the GRH standard of care (control group). Data analysis is being conducted. The results of the study: Provided clinicians with evidence for implementing the GGG in interventions, which in turn may benefit inpatient clients at the GRH; Informed stakeholders' decisions about clients' safe discharge and transition to home and community; and Supported researchers in designing a larger and more robust study.
Trial Details
NCT Number NCT07584408
Lead Sponsor University of Alberta
Collaborators: Glenrose Foundation
Conditions Compensation Strategies, Serious Games
Enrollment 15 participants
Start Date 2019-06-06
Primary Completion 2020-03-12 (estimated)
Study Completion 2020-03-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-13